We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.72B
AUM Growth
+$29.7M
Cap. Flow
+$160M
Cap. Flow %
5.89%
Top 10 Hldgs %
47.84%
Holding
110
New
9
Increased
24
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$71.7M
2
BHVN icon
Biohaven
BHVN
+$47.3M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$42.1M
4
SYY icon
Sysco
SYY
+$38.9M
5
AAPL icon
Apple
AAPL
+$34.8M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$48M
2
CI icon
Cigna
CI
+$45.6M
3
MCK icon
McKesson
MCK
+$30.5M
4
VZ icon
Verizon
VZ
+$23M
5
BCYC
Bicycle Therapeutics
BCYC
+$22.8M

Sector Composition

Rank Sector Weight
1 Healthcare 58.96%
2 Technology 10.09%
3 Communication Services 6.22%
4 Consumer Discretionary 5.49%
5 Financials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COGT icon
101
Cogent Biosciences
COGT
$7.19B
– –
-316,000
Closed -$2.12M
CRM icon
102
Salesforce
CRM
$158B
– –
-55,050
Closed -$16.6M
FATE icon
103
Fate Therapeutics
FATE
$293M
– –
-2,562,852
Closed -$18.8M
GPN icon
104
Global Payments
GPN
$23B
– –
-106,094
Closed -$14.2M
HLT icon
105
Hilton Worldwide
HLT
$72.1B
– –
-78,502
Closed -$16.7M
KRRO icon
106
Korro Bio
KRRO
$191M
– –
-73,821
Closed -$6.64M
QQQ icon
107
PUT
Invesco QQQ Trust
QQQ
$483B
– –
-195,000
Closed -$86.6M
SBUX icon
108
Starbucks
SBUX
$121B
– –
-172,951
Closed -$15.8M
TERN
109
DELISTED
Terns Pharmaceuticals
TERN
– –
-1,363,675
Closed -$8.95M
AKLI
110
DELISTED
Akili Inc
AKLI
– –
-3,841,718
Closed -$1.11M
1 2 3 4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Suvretta Capital Management held 110 positions worth $2.72B, up 1.1% from $2.69B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Suvretta Capital Management deployed $160M of net new capital in Q2 2024, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Sysco: 520,900 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Cigna, an estimated $45.6M trimmed.

  • Suvretta Capital Management's largest Q2 2024 buy was Sysco: 520,900 shares worth $37.2M.
  • Suvretta Capital Management added most to UnitedHealth in Q2 2024, an estimated $71.7M increase.
  • Suvretta Capital Management's biggest Q2 2024 reduction was Cigna, cutting an estimated $45.6M.
  • Suvretta Capital Management fully exited argenx in Q2 2024, selling an estimated $48M.
  • Suvretta Capital Management's ten largest holdings make up 48% of its $2.72B portfolio in Q2 2024.
  • Suvretta Capital Management opened 9 new positions and closed 12 in Q2 2024.
  • Suvretta Capital Management's portfolio value rose 1.1% quarter-over-quarter to $2.72B.

Based on Suvretta Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.